Cargando…

S2.4d Combination antifungal effects of eugenol with voriconazole against Candida tropicalis and Candida krusei strains isolated from the genital tract of mares

S2.4 VETERINARY MYCOLOGY RESEARCH, SEPTEMBER 21, 2022, 3:00 PM - 4:30 PM: OBJECTIVES: The objective of the current study was to investigate the possibility that eugenol synergizes the antifungal effects of voriconazole on genital isolates of Candida krusei and Candida tropicalis from mares. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharifzadeh, Aghil, Shokri, Hojjatollah, Nikaein, Donya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Oral Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511567/ http://dx.doi.org/10.1093/mmy/myac072.S2.4d

Ejemplares similares

P082 Synergistic activity, anti-adherence and anti-fungal abilities of fluconazole and voriconazole combined with thymol and carvacrol against C andida species
por: Sharifzadeh, Aghil, et al.
Publicado: (2022)

Efficacy of Syzygium aromaticum essential oil on the growth and enzymatic activity of pathogenic Candida albicans strains
por: Hekmatpanah, Ashkan, et al.
Publicado: (2022)

Antifungal activity of essential oils from Iranian plants against fluconazole-resistant and fluconazole-susceptible Candida albicans
por: Sharifzadeh, Aghil, et al.
Publicado: (2016)

Differential recognition of Candida tropicalis, Candida guilliermondii, Candida krusei, and Candida auris by human innate immune cells
por: Navarro-Arias, María J, et al.
Publicado: (2019)

P357 Update on risk factors for Candida krusei-Fungemia
por: Jansen, Julia C., et al.
Publicado: (2022)

Clinical Characteristics of Turkish Women with Candida krusei Vaginitis and Antifungal Susceptibility of the C. krusei Isolates
por: Güzel, Ahmet Bariş, et al.
Publicado: (2013)

Promising antifungal activity of new oxadiazole against Candida krusei
por: Faria, Daniella Renata, et al.
Publicado: (2020)

S5.1d Mechanisms of azole antifungal resistance in clinical isolates of Candida tropicalis
por: Ghosh, Anup, et al.
Publicado: (2022)

P017 Echinocandin resistance mechanism in Candida tropicalis and Candida glabrata
por: Sharma, Dipti, et al.
Publicado: (2022)

Presumptive identification of Candida species other than C. albicans, C. krusei, and C. tropicalis with the chromogenic medium CHROMagar Candida
por: Hospenthal, Duane R, et al.
Publicado: (2006)

Cardiac Candida krusei infection
por: Wiwanitkit, Viroj
Publicado: (2010)

Antifungal susceptibility profile of yeasts isolated from the oral cavity of cats
por: Nikaein, Donya, et al.
Publicado: (2023)

Mechanism of Antifungal Activity by 5-Aminoimidazole-4-Carbohydrazonamide Derivatives against Candida albicans and Candida krusei
por: Cerqueira, Fátima, et al.
Publicado: (2021)

Repetitive sequences based on genotyping of Candida albicans isolates obtained from Iranian patients with human immunodeficiency virus
por: Tamai, Iradj Ashrafi, et al.
Publicado: (2014)

Molecular Phylogenetic Analysis of Candida krusei
por: Domán, Marianna, et al.
Publicado: (2022)

Antifungal Activity and Mode of Action of Miltefosine Against Clinical Isolates of Candida krusei
por: Wu, Yongqin, et al.
Publicado: (2020)

Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis
por: Ishida, Kelly, et al.
Publicado: (2011)

In vitro antifungal potency of the moronecidin-like peptide against Candida albicans, Candida glabrata, and Candida tropicalis
por: Amirrajab, Nasrin, et al.
Publicado: (2023)

Morphological characteristics of Candida albicans, Candida krusei, Candida guilliermondii, and Candida glabrata biofilms, and response to farnesol
por: Sachivkina, Nadezhda, et al.
Publicado: (2021)

Mechanisms of azole antifungal resistance in clinical isolates of Candida tropicalis
por: Paul, Saikat, et al.
Publicado: (2022)

Antifungal effects of eugenol on Candida albicans adherence to denture polymers
por: Zanul Abidin, Zubaidah, et al.
Publicado: (2023)

Understanding the Antifungal Mechanism of Ag@ZnO Core-shell Nanocomposites against Candida krusei
por: Das, Bhaskar, et al.
Publicado: (2016)

P015 A study to demonstrate heteroresistance and tolerance to azoles in Candida tropicalis
por: Reddy, Snigdha, et al.
Publicado: (2022)

Upregulation of the ERG11 gene in Candida krusei by azoles
por: Tavakoli, M., et al.
Publicado: (2010)

Renal allograft pyelonephritis and fungemia due to Candida krusei
por: Westervelt, Justin D., et al.
Publicado: (2014)

Genetic Differentiation, Diversity, and Drug Susceptibility of Candida krusei
por: Gong, Jie, et al.
Publicado: (2018)

Case report: Candida krusei spondylitis in an immunocompromised patient
por: Overgaauw, Audrey J. C., et al.
Publicado: (2020)

Synergistic Antifungal Activity of Chitosan with Fluconazole against Candida albicans, Candida tropicalis, and Fluconazole-Resistant Strains
por: Lo, Wei-Hsuan, et al.
Publicado: (2020)

The emerging threat antifungal-resistant Candida tropicalis in humans, animals, and environment
por: Lima, Ricardo, et al.
Publicado: (2022)

Blood Stream Infections by Candida glabrata and Candida krusei: A Single-Center Experience
por: Choi, Hee Kyoung, et al.
Publicado: (2009)

P008 Molecular mechanisms associated with fluconazole resistance and genetic diversity in clinical Candida krusei isolates from North India
por: Jain, Kusum, et al.
Publicado: (2022)

P373 Does biofilm forming capacity of Candida tropicalis vary with echinocandin susceptibility?
por: Ritika,, et al.
Publicado: (2022)

P149 Short tandem repeat genotyping of South American Candida tropicalis isolates
por: Spruijtenburg, Bram, et al.
Publicado: (2022)

Effect of Eugenol on Cell Surface Hydrophobicity, Adhesion, and Biofilm of Candida tropicalis and Candida dubliniensis Isolated from Oral Cavity of HIV-Infected Patients
por: de Paula, Suelen Balero, et al.
Publicado: (2014)

A cluster of Candida krusei infections in a haematological unit
por: Hautala, Timo, et al.
Publicado: (2007)

Risk Factors and Mortality Associated with Candida krusei Bloodstream Infections
por: Kronen, Ryan, et al.
Publicado: (2017)

Biosorption Performance of Encapsulated Candida krusei for the removal of Copper(II)
por: Luk, Chi Him Jim, et al.
Publicado: (2017)

P079 Virulence factors and azole-resistant mechanism of Candida tropicalis isolated from candidemia
por: Sarvestani, Elahe Sasani, et al.
Publicado: (2022)

Virulence Factors Contributing to Pathogenicity of Candida tropicalis and Its Antifungal Susceptibility Profile
por: Deorukhkar, Sachin C., et al.
Publicado: (2014)

Mechanism of Antifungal Action of Monoterpene Isoespintanol against Clinical Isolates of Candida tropicalis
por: Contreras Martínez, Orfa Inés, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k2vqc0rudkeeenvcihiqq6a5b5